ELRIG Drug Discovery 2021
ELRIG Drug Discovery 2021 Read Post »
Publication: Applying C. elegans to industrial drug discovery
Just published in Frontiers in Aging: Applying C. elegans to industrial drug discovery
Publication: Applying C. elegans to industrial drug discovery Read Post »
Research on ageing leader Magnitude Biosciences expands its project delivery team to meet increased demand
Hannah Raddings (right) and Alana Mullins (centre) with Magnitude Biosciences Head of Experiments Michael Fasseas (left). Durham, UK – July
Could C. elegans be the key to slowing ageing?
Originally published in Health Tech World: https://www.htworld.co.uk/interviews/could-c-elegans-be-the-key-to-slowing-ageing/ Health Tech World spoke to Magnitude Biosciences about its groundbreaking work with C. elegans and
Could C. elegans be the key to slowing ageing? Read Post »
Frontiers in Longevity: How do we slow human ageing?
How do we slow the process of Ageing? David Weinkove discusses learnings from the Clubhouse event “The Future of Longevity II”
Frontiers in Longevity: How do we slow human ageing? Read Post »
Unlocking the microbiome as a target for drug discovery using C. elegans
The human microbiome holds great promise for modern medicine but is still largely a mystery to scientists
Unlocking the microbiome as a target for drug discovery using C. elegans Read Post »
C. elegans to accelerate industrial drug discovery and address the costs and challenges of early preclinical research
Magnitude Bioscience CEO, David Weinkove, discusses the application of C. elegans to accelerate the industrial drug discovery process
Translating groundbreaking drug development ideas into therapies with worms: takeaways from the joint ELRIG and British Pharmacological Society 2021 meeting
Some fascinating ideas came out of the Translating Ideas Into Therapies meeting held June 30-July 1 2021 by ELRIG and the British Pharmacological Society
Developing a System to Quantify Efficacy of Neurodegeneration Therapeutics Using Automated Monitoring of C. elegans
Check out our poster showing how we can quantify the efficacy of neurodegeneration models
